Welcome to our dedicated page for Health Advance I news (Ticker: HADV), a resource for investors and traders seeking the latest updates and insights on Health Advance I stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Health Advance I's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Health Advance I's position in the market.
Health Advance Inc (OTC: HADV) and SoEquity have initiated business planning with Southern Glazer's for their hemp-derived CBD infused beverage venture. The partnership plans to distribute hemp-derived THC brands through national distributors including Total Wine & More and ABC Fine Wine & Spirits.
The company is refining its launch strategy following test marketing of CBD infused beverages under Courtship Wines, shifting focus toward hemp-derived THC beverages due to strong consumer interest. Calvin Frye, SoEquity 's CEO and cannabis industry expert, leads the Courtship Wines project.
The Health Advance-SoEquity alliance aims to combine social equity and merit in business categories where minority-owned enterprises seek partnerships. SoEquity is preparing for a U.S. federal Tier II Regulation A+ public offering of $75 Million, focusing on mentoring and financing social equity enterprises.
Health Advance Inc (OTC: HADV) and SoEquity have launched a cannabis accelerator program, approving their first social equity cannabis license owner, InLabs2 of Springfield, Illinois. The program aims to boost business success through targeted mentorship and funding, while sharing benefits with public investors.
The alliance's business model focuses on identifying qualified social equity license owners in states with capped licensing, providing expertise, mentorship, and financing to maximize performance. InLabs2, led by William Bishop III, has agreed to a joint venture that provides the Health Advance/SoEquity alliance with partial ownership and profit sharing.
Health Advance is supporting SoEquity 's qualification with the SEC for a $75 Million public offering under Regulation A+. The initiative represents the first time public investors have had access to social equity targeted deal flow within the cannabis sector.
Health Advance, Inc. (HADV) is set to launch its new CBD-infused de-alcoholized wine, leveraging positive trade press feedback from recent samples. Initially planned for small retailers, the strategy has shifted towards a major launch with a respected supermarket chain, potentially generating a seven-digit opening sales volume. The beverages, available in three varietals, contain 25mg of broad-spectrum CBD and are crafted from high-quality grapes. The company is also advancing other projects, including nutraceutical sales trials and a spin-off in female sexual health.
Health Advance, Inc. (OTC PINK:HADV) announces the second printing of Dr. Alvin Pettle's book, My Prescription for Life, reflecting high reader satisfaction. This collaboration focuses on launching immune-boosting nutraceuticals and health solutions derived from Dr. Pettle's clinical experience. The first product range targets immune support, with plans for additional offerings in reproductive health. The company aims to enhance personal wellness and has garnered positive feedback from patients. The release is part of Health Advance's broader initiative to develop proprietary health products.
Health Advance, Inc (HADV) announced significant progress in addressing lingering health issues post-COVID. The company has selected a contract manufacturer for its proprietary supplement aimed at improving well-being among these patients. Two phases of the product launch include initial trial manufacturing and subsequent larger-scale production. Dr. Alvin Pettle leads the science team, focusing on creating user-friendly supplement kits. With rising demand for such products, Health Advance positions itself to capitalize on this growing market.
Health Advance, Inc. (OTC PINK:HADV) has commenced distribution of its innovative CBD infused de-alcoholized wine under its 66° Beverage Company brand. This product is the first of its kind licensed in New York, featuring a unique formulation available in Rosé, White, and Red Wine variants, each containing 25mg of CBD.
Targeting health-conscious consumers, the wines are made from non-GMO California grapes and contain lower calories and sugar. The initial product allocation is aimed at qualified retailers and marketing organizations to boost brand outreach.
Health Advance, Inc. (OTC PINK:HADV) has initiated production of its innovative CBD infused de-alcoholized wine, branding it under the new 66° Beverage Company. The first manufacturing run allocates 19,400 units for early customers, launching in August. The company has partnered with Publicity For Good to enhance its market presence and communicate effectively with industry stakeholders. Health Advance aims to position this unique beverage as a significant player in the expanding adult lifestyle market, reflecting a commitment to innovation and consumer engagement.
Health Advance, Inc. (OTC PINK:HADV) announced the upcoming launch of its CBD infused de-alcoholized wine under the brand 66° Beverage Company, with the first batch expected for distribution by the end of July 2022. The company recently secured a production license from New York State, enabling it to proceed with its innovative beverage offerings. Industry trends indicate a growing interest in non-alcoholic beverages, with the global market nearing $1 trillion. The president emphasized the quality of retailer interest and indicated that cash flow from sales will be reflected in Q3 2022 filings.
Health Advance, Inc. (OTC PINK:HADV) has appointed David Katz, MBA, as President and Co-Founder of its new CBD infused wine beverage brand, 66° Beverage Company. The brand's launch will occur through the joint venture with Courtship Wines, which recently received a license from New York State's Cannabinoid Hemp Program. An initial production run of 60,000 bottles in three varietals is underway. Katz brings significant experience from the food and beverage sectors, aiming to position the brand as an innovator in the adult lifestyle beverage market.
Health Advance, Inc. (OTC PINK:HADV) has received licensing approval from New York State for its CBD infused beverages through its joint venture, Courtship Wines. This marks a significant milestone in the company's strategic development since 2021, enabling them to launch their CBD product line. The management indicates that adequate funding is secured, and initial orders are already in place. Upcoming announcements will detail product offerings, including flavor and packaging, as the company activates its manufacturing processes.